Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Pittsburgh, Pennsylvania 15213


The purpose of this study is to compare the effectiveness and safety of atomoxetine in the treatment of adolescents with coexisting alcohol or substance use disorders and Attention Deficit Hyperactivity Disorder (ADHD).


Inclusion Criteria: - Adolescents, ages 13-18 - Meets criteria for alcohol and/or substance use disorder and attention deficit hyperactivity disorder. Exclusion Criteria: - Adolescents who are pregnant. - Have a history of seizure disorder, other neurological or medical disorder for which medication treatment may present a considerable risk. - History of pervasive development disorder, schizophrenia or other psychotic disorders, organic mental disorders or eating disorders. - Currently on other psychotropic medications from which discontinuation would present a significant risk. - A current episode of major depressive disorder or a diagnosis of bipolar disorder. - Diagnosis of dependence for any substance other than marijuana. - Adolescents with a full-scale IQ below 80.



Primary Contact:

Principal Investigator
Oscar G. Bukstein, MD
Western Psychiatric Institute and Clinic

Backup Contact:


Location Contact:

Pittsburgh, Pennsylvania 15213
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.